Diagnostic Approach to Recurrent Pancreatitis

Diagnostic Algorithm

The American Gastroenterological Association recommends proceeding with endoscopic ultrasound (EUS) as the next diagnostic step after a normal MRCP, as it is superior to MRCP for detecting occult causes of recurrent pancreatitis, particularly microlithiasis, early chronic pancreatitis changes, and small pancreatic lesions that MRCP may miss 1
EUS is the preferred diagnostic test after an unrevealing initial evaluation including normal MRCP, as it provides higher diagnostic yield than MRI/MRCP for identifying probable causes of recurrent acute pancreatitis (odds ratio 3.79) 1
Schedule EUS 2-6 weeks after resolution of the most recent acute episode, as persistent inflammatory changes may hinder evaluation of subtle lesions and underlying chronic pancreatitis 1, 2

Pancreas divisum is present in 6-10% of individuals and may cause recurrent pancreatitis in a subset of patients, though MRCP should have detected this 1, 2
Occult malignancy, particularly ampullary or pancreatobiliary tumors, must be excluded, as it is found in up to 12% of recurrent acute pancreatitis cases 1

If pancreas divisum is confirmed, exercise extreme caution before proceeding with endoscopic therapy, as the role of pancreas divisum in causing recurrent pancreatitis is controversial 1, 2
Minor papilla sphincterotomy carries significant risks, including a 10-15% risk of post-ERCP pancreatitis and up to 19% risk of post-papillotomy stenosis that may worsen recurrence 2
Consider minor papilla intervention only if there are overt radiologic findings of ductal outflow obstruction with dilated dorsal duct 2
Evidence supporting endoscopic therapy is weak, with only one small randomized trial (19 patients) showing benefit 2

If EUS is unrevealing, consider secretin-enhanced MRCP if available, though clinical utility is limited by availability and interpretation variability 1, 2
Avoid empirical ERCP with biliary sphincterotomy in patients with unexplained recurrent pancreatitis and standard pancreatic ductal anatomy, as benefits are uncertain and procedure-related adverse events can be severe 3

The American Gastroenterological Association recommends that a thorough history should focus on previous gallstone symptoms, medication use, family history of pancreatic disease, trauma history, and presence of autoimmune diseases 4, 5
Initial laboratory tests should include serum amylase or lipase, triglyceride levels, calcium levels, and liver chemistries (bilirubin, AST, ALT, alkaline phosphatase) to identify underlying causes of pancreatitis 4, 5
Abdominal ultrasound should be performed to look for cholelithiasis or choledocholithiasis, and should be repeated if initially negative 4, 6
CT scan should be performed to exclude pancreatic malignancy, especially in patients over 40 years of age 4, 5

Endoscopic ultrasound (EUS) is preferred as the initial advanced test for recurrent idiopathic pancreatitis as it can detect microlithiasis, small pancreatic tumors, and anatomical variations like pancreas divisum 4, 7
ERCP should be considered after EUS if EUS findings suggest biliary or pancreatic duct abnormalities, or if there are minor papilla abnormalities 4, 7
ERCP should be performed by an experienced endoscopist with capabilities for therapeutic intervention including sphincterotomy and pancreatic duct stent placement 4, 5

Fasting lipid and calcium levels should be measured if not done during the acute phase to identify potential causes of pancreatitis 6, 7
MRI/MRCP can demonstrate most duct stones and ductal anomalies such as pancreas divisum 7

The goal should be to identify an underlying cause, as the etiology of acute pancreatitis should be established in at least 75-80% of cases 4, 6
General supportive care during acute episodes includes fluid resuscitation, pain control, and correction of electrolyte abnormalities 4, 5, 8

Accepting "idiopathic" as a diagnosis without thorough investigation - the incidence should be no more than 20-25% 6, 7
Performing invasive procedures like ERCP without prior non-invasive imaging 4, 7

The initial workup should identify the underlying cause in ≥ 75 %–80 % of cases; labeling a case “idiopathic” without thorough investigation is considered inadequate. 9

Endoscopic ultrasound (EUS) reveals a plausible etiology in 29 %–88 % of patients whose pancreatitis remains unexplained after standard testing. 10

Empirical ERCP is not recommended for patients with unexplained recurrent pancreatitis and normal pancreatic duct anatomy because the benefit is uncertain and the risk of serious complications is high. 10
When ERCP is performed, biliary sphincterotomy alone is preferred over combined biliary‑and‑pancreatic sphincterotomy to lower the incidence of procedure‑related adverse events. 10

Approximately 35 % of individuals with recurrent acute pancreatitis will eventually develop chronic pancreatitis. 10